3D viewing software WATS3D

diagnosticacquisitionscreening

Adjunctive use of WATS3D helps overcome sampling error that is inherent in the Seattle protocol WATS3D provides physicians with a more effective endoscopic method of sampling tissue from the esophagus. It allows: Sampling of much more at-risk mucosa, which reduces sampling error Acquisition of deep mucosal tissue which is the location where pre-cancer (dysplasia) develops initially. Limitations of the Seattle protocol: 96% of the endoscopically suspect area remains completely unsampled Significant sampling error and false negative results Poor agreement rate among pathologists in diagnosing dysplasia Time-consuming and labor intensive With WATS3D, areas identified by the neural network as the most likely to be dysplastic, pathologists are able to quickly identify and grade dysplasia in higher percentage of positive cases and with far greater diagnostic accuracy. Traditional esophageal histopathology on forceps biopsy specimens are well-known to suffer from high interobserver variability and high miss rates of dysplasia and cancer. WATS3D pathologists gathers information from both the 3D images as well as the cytology specimens using histocytology techniques to make more accurate diagnoses, and genetic testing allows pathologists to consistently make a diagnosis based on the most advanced science available.